Gut microbiome may predict response to biologic therapy for inflammatory bowel disease
Monday, May 15, 2017 - 13:32
in Health & Medicine
Researchers have identified differences in the composition and the function of the gut microbiome between patients for whom treatment with a monclonal antibody-based drug was effective in inducing remission of inflammatory bowel disease symptoms and those for whom it was not.